Daiichi Sankyo Dividend yield

Daiichi Sankyo is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Daiichi Sankyo is a company from Japan, and his stocks are publicly traded.

Daiichi Sankyo paid a total dividend of 45,276 million JPY last year, for a market value of 2,275,128 millions (Market Cap 2,227,572 millions). Dividend per share of Daiichi Sankyo is 69.87 JPY, and his stock market price 3,511.00 JPY.

According to the chart below, where dividend yield is displayed, Daiichi Sankyo has a dividend yield of 1.99%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare Daiichi Sankyo dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Japan.

Daiichi Sankyo Dividend Payout

About the ability of Daiichi Sankyo to maintain his current dividend of JPY 69.87 per share, an amount that accounts for 1.99%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Daiichi Sankyo payout on ernings is currently 56.92%, which is higher than the market average, and companies of Health Care industry, which are 40.41% and 28.58% respectively. Both figures show that Daiichi Sankyo can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Daiichi Sankyo is JPY 167.19 per share, which is higher than the dividend per share paid by the company of JPY 69.87, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Daiichi Sankyo, compared againt world market average, Japan companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Daiichi Sankyo Stock performance

Finally, last moth Daiichi Sankyo showed a return of -15.70% compared to a worldwide -5.60% average, and a -7.73% of Health Care firms. Over the last year, the company obtained a 19.50% versus a worldwide performance of a -11.41%. More detailed information can be seen in the following graph for Japan and Pharmaceuticals and Biotechnology firms.